Paediatric meningococcal meningitis in France: ACTIV/GPIP network results;Méningites à méningocoques de l'enfant en France: résultats de l'observatoire ACTIV/GPIP

Archives de Pediatrie

Volumn 19, Issue SUPPL.2, 2012, Pages

  Levy, C ^a,b   Taha, M K ^c   Bingen, E ^a,d   Cohen, R ^a,b,e  

^a GPIP Groupe de Pathologie Infectieuse Pédiatrique   (France)

^b ACTIV   (France)

^c CENTRE NATIONAL DE RECHERCHES MÉTÉOROLOGIQUES   (France)

^d Service de Microbiologie Hop Robert Debré   (France)

^e CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; MENINGOCOCCUS VACCINE;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL FEATURE; EPIDEMIC MENINGITIS; FATALITY; FRANCE; HUMAN; INFANT; INFECTION CONTROL; LUMBAR PUNCTURE; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; RISK FACTOR; SHOCK; VACCINATION;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MENINGITIS, MENINGOCOCCAL; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS; NEISSERIA MENINGITIDIS, SEROGROUP B; NEISSERIA MENINGITIDIS, SEROGROUP C; RISK FACTORS; SEROTYPING; SOCIETIES, MEDICAL; SPINAL PUNCTURE; SURVIVAL RATE; TREATMENT OUTCOME; VACCINATION; VACCINES, CONJUGATE;

EID: 84865047935     PISSN: 0929693X     EISSN: 1769664X     Source Type: Journal    
DOI: 10.1016/S0929-693X(12)71273-3     Document Type: Article

References (12)

1. Bingen E., Levy C., de la Rocque F., et al. Bacterial meningitis in children: a French prospective study. Clin Infect Dis 2005, 41:1059-1063.
2. Parent du Châtelet I., Taha M.K., Le poutre A., et al. Les infections invasives à méningocoque en France en 2010. Bull Epidemiol Hebd 2011, 45-46.
3. Avis du HCSP relatif à la vaccina tion par le vaccin méningococcique conjugué de sérogroupe C. 2009.
4. Vie Le sage F., Levy C., Thiebault G., et al. Couverture vaccinale: yes we can ! Le pédiatre 2011, 245.
5. Levy C., Taha M.K., Weil Olivier C., et al. Association of meningococcal phenotypes and genotypes with clinical characteristics and mortality of meningitis in children. Pediatr Infect Dis J 2010, 29:618-623.
6. Taha M.K., Achtman M., Alonso J.M., et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 2000, 356:2159.
7. Traore Y., Njanpop- Lafourcade B.M., Adjogble K.L., et al. The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis 2006, 43:817-822.
8. Thigpen M.C., Whitney C.G., Messonnie r N.E., et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med 2011, 364:2016-2025.
9. Trotter C.L., Chandra M., Cano R., et al. A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev 2007, 31:27-36.
10. Zarantonelli M.L., Lancellotti M., Deghmane A.E., et al. Hyperinvasive genotypes of Neisseria meningitidis in France. Clin Microbiol Infect 2008, 14:467-472.
11. Trotter C.L., Ramsay M.E. Vaccinatio n against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines. FEMS Microbiol Rev 2007, 31:101-107.
12. Pollard A.J. Global epidemiology o f meningococcal disease and vaccine efficacy. Pediatr Infect Dis J 2004, 23(12 Suppl):S274-S279.